Longwood Fund

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events
  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

Be Bio: bringing the B to cell therapy

October 23, 2020

Can B cells break the boundaries of cell therapy? Longwood startup has $52M to prove a new engineering tech

October 22, 2020

Longwood, Atlas Venture inject $52M into cell therapy startup

October 22, 2020

Be Biopharma debuts with $52M to advance engineered B-cell therapies

October 22, 2020

Be Biopharma Launches with $52 Million Series A Financing to Advance B Cells as Medicines

October 22, 2020

Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2, most of which are not located in the Spike protein

October 21, 2020
« Older Entries
Newer Entries »

Longwood Fund

The Prudential Tower

800 Boylston Street
Suite 1715
Boston, MA, 02199

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

© Longwood Fund. All Rights Reserved